EDGAR Filing Documents for 0001193805-16-003200

Form F-6EF - Registration of American Depository Receipt shares, immediately effective:

SEC Accession No. 0001193805-16-003200

Filing Date

2016-05-09

Accepted

2016-05-09 14:07:46

Documents

Effectiveness Date

2016-05-09

Document Format Files

Seq	Description	Document	Type	Size
1		e615004_f6ef-astrazeneca.htm	F-6EF	137657
2		e615004_ex99-ai.htm	EX-99.(A)(I)	180473
3		e615004_ex99-d.htm	EX-99.(D)	15676
4		e615004_ex99-e.htm	EX-99.(E)	7173
5	GRAPHIC	pbwtlogo.jpg	GRAPHIC	15072
	Complete submission text file	0001193805-16-003200.txt		363432

Mailing Address 2 KINGDOM STREET - LEGAL DEPARTMENT LONDON X0 W2 6BD

Business Address 2 KINGDOM STREET - LEGAL DEPARTMENT LONDON X0 W2 6BD 011 44 20 7304 5000

ASTRAZENECA PLC (Subject) CIK: 0000901832 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: F-6EF | Act: 33 | File No.: 333-211233 | Film No.: 161631027
SIC: 2834 Pharmaceutical Preparations

Mailing Address 388 GREENWICH STREET, 14TH FLOOR NEW YORK NY 10013

Business Address 388 GREENWICH STREET, 14TH FLOOR NEW YORK NY 10013 212-816-6647

Citibank,N.A./ADR (Filed by) CIK: 0001472033 (see all company filings)

IRS No.: 521568099 | State of Incorp.: DC | Fiscal Year End: 1231
Type: F-6EF